BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23612975)

  • 1. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.
    Gillis J; Schipper-Krom S; Juenemann K; Gruber A; Coolen S; van den Nieuwendijk R; van Veen H; Overkleeft H; Goedhart J; Kampinga HH; Reits EA
    J Biol Chem; 2013 Jun; 288(24):17225-37. PubMed ID: 23612975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios.
    Månsson C; Kakkar V; Monsellier E; Sourigues Y; Härmark J; Kampinga HH; Melki R; Emanuelsson C
    Cell Stress Chaperones; 2014 Mar; 19(2):227-39. PubMed ID: 23904097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation.
    Rodríguez-González C; Lin S; Arkan S; Hansen C
    Sci Rep; 2020 May; 10(1):8130. PubMed ID: 32424160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic expression of the chaperone DNAJB6 results in non-cell autonomous protection in Huntington's disease.
    Bason M; Meister-Broekema M; Alberts N; Dijkers P; Bergink S; Sibon OCM; Kampinga HH
    Neurobiol Dis; 2019 Apr; 124():108-117. PubMed ID: 30408590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human DnaJB6 Antiamyloid Chaperone Protects Yeast from Polyglutamine Toxicity Separately from Spatial Segregation of Aggregates.
    Kumar J; Kline NL; Masison DC
    Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAJB chaperones suppress destabilised protein aggregation via a region distinct from that used to inhibit amyloidogenesis.
    McMahon S; Bergink S; Kampinga HH; Ecroyd H
    J Cell Sci; 2021 Apr; 134(7):. PubMed ID: 33674449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Aβ42) aggregates leads to sub-stoichiometric inhibition of amyloid formation.
    Månsson C; Arosio P; Hussein R; Kampinga HH; Hashem RM; Boelens WC; Dobson CM; Knowles TP; Linse S; Emanuelsson C
    J Biol Chem; 2014 Nov; 289(45):31066-76. PubMed ID: 25217638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation.
    Månsson C; van Cruchten RTP; Weininger U; Yang X; Cukalevski R; Arosio P; Dobson CM; Knowles T; Akke M; Linse S; Emanuelsson C
    Biochemistry; 2018 Aug; 57(32):4891-4902. PubMed ID: 30024736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRCP1 Conveys Resistance to Polyglutamine Aggregation.
    Santarriaga S; Haver HN; Kanack AJ; Fikejs AS; Sison SL; Egner JM; Bostrom JR; Seminary ER; Hill RB; Link BA; Ebert AD; Scaglione KM
    Mol Cell; 2018 Jul; 71(2):216-228.e7. PubMed ID: 30029002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
    Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
    J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.
    Muchowski PJ; Schaffar G; Sittler A; Wanker EE; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7841-6. PubMed ID: 10859365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.
    Hageman J; Rujano MA; van Waarde MA; Kakkar V; Dirks RP; Govorukhina N; Oosterveld-Hut HM; Lubsen NH; Kampinga HH
    Mol Cell; 2010 Feb; 37(3):355-69. PubMed ID: 20159555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of polyglutamine protein toxicity by co-expression of a heat-shock protein 40 and a heat-shock protein 110.
    Kuo Y; Ren S; Lao U; Edgar BA; Wang T
    Cell Death Dis; 2013 Oct; 4(10):e833. PubMed ID: 24091676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain independent manner.
    Ito N; Kamiguchi K; Nakanishi K; Sokolovskya A; Hirohashi Y; Tamura Y; Murai A; Yamamoto E; Kanaseki T; Tsukahara T; Kochin V; Chiba S; Shimohama S; Sato N; Torigoe T
    Biochem Biophys Res Commun; 2016 Jun; 474(4):626-633. PubMed ID: 27133716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins.
    Krobitsch S; Lindquist S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1589-94. PubMed ID: 10677504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells.
    Deshayes N; Arkan S; Hansen C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Versatile members of the DNAJ family show Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G.
    Kakkar V; Kuiper EF; Pandey A; Braakman I; Kampinga HH
    Sci Rep; 2016 Oct; 6():34830. PubMed ID: 27713507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.
    Nagai Y; Fujikake N; Popiel HA; Wada K
    Curr Pharm Biotechnol; 2010 Feb; 11(2):188-97. PubMed ID: 20166962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse Model.
    Kakkar V; Månsson C; de Mattos EP; Bergink S; van der Zwaag M; van Waarde MAWH; Kloosterhuis NJ; Melki R; van Cruchten RTP; Al-Karadaghi S; Arosio P; Dobson CM; Knowles TPJ; Bates GP; van Deursen JM; Linse S; van de Sluis B; Emanuelsson C; Kampinga HH
    Mol Cell; 2016 Apr; 62(2):272-283. PubMed ID: 27151442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.